Live Quote · NASDAQCGEMHealthcare· Biotechnology

Cullinan Therapeutics, Inc.

$8.89▼ 1.98%($-0.18)
MKT CAP $577.15MNEXT EARNINGS Mar 9, 2027
50%
Bullish
TickerSpark Score
44/100
▌ Weak
70
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CGEM research report →

Analyst Price Target
$34.33+286.2% vs. today

Range $27 – $41

Analyst RatingBuy
8 Buy0 Hold0 Sell

Price Chart

+7.34% · this period
$22.95$15.70$8.45Nov 19May 22Nov 19
52-Week Range3% of range
Low
$8.47
Current
$8.89
High
$23.19